Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ACAD
#1534
Acadia Pharmaceuticals Inc.
22.0
8
USD
+2.89%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.89%
Aylık Değişim
+5.04%
6 aylık değişim
+8.18%
Yıllık Değişim
+48.59%
Önceki Kapanış
21.4
6
Open
21.9
4
Bid
Ask
Low
21.9
3
High
22.1
3
Hacim
326
Piyasalar
ABD Borsası
Sağlık Hizmetleri
ACAD
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
160.05 M
161.2 M
162.23 M
164.77 M
166.79 M
170.49 M
—
Valuation ratios
Enterprise value
8.23 B
3.62 B
2.53 B
4.9 B
2.74 B
4.38 B
13.68 B
Price to earnings ratio
—
—
-12.18
-83.41
13.49
11.61
53.72
Price to sales ratio
—
—
0.01
0.01
3.19
4.24
13.98
Price to cash flow ratio
—
—
-0.02
0.3
19.36
41.32
97.18
Price to book ratio
—
—
0.01
0.01
4.17
3.7
7.12
Enterprise value to EBITDA ratio
-30.14
-22.95
-11.29
-61.62
7.43
43.65
155.34
Profitability ratios
Return on assets %
-0.36
-0.24
-0.37
-0.08
0.19
0.25
0.27
Return on equity %
-0.45
-0.31
-0.54
-0.14
0.31
0.32
0.36
Return on invested capital %
-2 612.98
-927.62
-1 116.07
-331.41
423.81
314.06
333.1
Gross margin %
97.69
97.76
98.03
94.27
91.46
91.69
366.81
Operating margin %
-64.87
-35.2
-43.23
-10.1
24.1
9.78
39.09
EBITDA margin %
-61.81
-32.53
-43.37
-10.94
38.52
9.36
37.34
Net margin %
-63.74
-34.67
-41.76
-8.44
23.64
36.49
139.94
Liquidity ratios
Quick ratio
6.68
6.28
3.95
2.26
2.14
3.43
11.27
Current ratio
6.77
6.43
4.04
2.42
2.38
3.83
12.64
Inventory turnover
1.27
0.91
0.79
1.6
1.24
0.88
0.85
Asset turnover
0.56
0.65
0.8
1.09
0.99
0.78
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-705.3
101.95
0.95
0.65
0.65
EBIT per share
—
—
-1 382.93
-447.93
1.39
0.62
0.62
EBITDA per share
—
—
-1 387.32
-485
2.22
0.59
0.59
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
2 578.03
2 678.96
4.54
4.82
18.37
Net current asset value per share
—
—
3 141.56
3 761.01
5.64
6.25
23.45
Tangible book value per share
—
—
2 476.53
2 235.79
3.68
6.58
19.37
Working capital per share
—
—
2 364.55
2 208.97
3.27
4.62
15.97
Book value per share
—
—
2 476.53
2 635.56
4.4
7.22
22.04
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Haberler
CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?
Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?
Acadia Pharma EVP Schneyer 60 bin dolarlık hisse sattı
Acadia Pharmaceuticals yetkilisi 22.866 dolar değerinde hisse sattı
Biotech Is Holding Steady In 2026 (NASDAQ:IBB)
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Acadia Pharma EVP Schneyer 159 bin dolarlık hisse sattı
Acadia Pharmaceuticals yöneticisi 41.895 dolar değerinde hisse sattı
Acadia EVP Thompson, opsiyon kullanımı sonrası 73 bin dolarlık hisse sattı
Acadia Pharma CEO’su 249 bin dolarlık hisse sattı
Acadia EVP Rhodes, opsiyon kullanımı sonrası 82 bin dolarlık hisse sattı
BofA, Acadia Pharmaceuticals hissesini değerleme üzerine yükseltti